ISRCTN33329207已完成未知
A multicentre randomised trial to assess whether increased dietary fibre intake (using a fibre supplement or high fibre foods) reduces laxative requirement in free living Peritoneal Dialysis patients
Portsmouth Hospitals NHS Trust (UK)0 个研究点目标入组 100 人开始时间: 2010年6月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. PD patient for minimum 3 months
- •2. Regular user of laxatives
- •3. Aged greater than 18 years, either sex
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
进行中（未招募）
不适用
Randomized multicenter study to compare survival and clinical improvement of methicillin resistant Staphylococcus aureus bacteremia in hospitalized patients when they are treated with combination of Daptomycin plus Fosfomycin versus Daptomycin alone.EUCTR2013-000586-37-ESMiquel Pujol Rojo (Infectious Diseases Service-Hospital Universitari de Bellvitge-IDIBELL)
进行中（未招募）
1 期
Trial to evaluate the efficacy of fentanyl pectin nasal spray (FPNS) versus Physician Choice (PC) - Usual Care (UC), in patients with head and neck cancer undergoing radiotherapy.Patients with head and neck cancer .MedDRA version: 21.1Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-005110-30-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI158
进行中（未招募）
1 期
A multicenter randomized trial to evaluate the efficacy of tocilizumab in patients with severe Coronavirus Disease 2019 (Covid-19) pneumonia failing glucocorticoids.polmonite severa da coronavirus 2019MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-005291-35-ITAOU POLICLINICO DI MODENA640
招募中
1 期
A multicenter randomized trial to evaluate the efficacy of pioglitazone to improve renal outcome in ANCA-associated vasculitis - RENATOANCA-associated vasculitisCTIS2022-501057-36-00Assistance Publique Hopitaux De Paris126
进行中（未招募）
不适用
Multicenter randomized study to assess the efficacy and the safety of two therapeutic regimens(high dose of imiglucerase versus co-administration of imiglucerase and miglustat) in type I Gaucher disease patients who have not responded to previous treatment with low dose imiglucerase - NDMedDRA version: 9.1Level: LLTClassification code 10018048Term: Gaucher's diseaseGAUCHER diseaseEUCTR2007-005516-61-ITISTITUTO GIANNINA GASLINI